Juq-016 -

General discussions on social platforms like Facebook and community forums often highlight Kinoshita as a popular figure within this niche, though some fans argue she remains underrated in her home market compared to her international following. Note on Content:

| Category | Info | |----------|------| | Release Date | 2023 | | Series | Super Exclusive Madonna | | Actress | Yumi Kazama | | Studio | MADONNA | | Duration | ~120 min | JUQ-016

JUQ‑016 is a next‑generation small‑molecule modulator of the , discovered by Jupiter Therapeutics (JUQ) in early 2024. It was initially identified through a phenotypic screen for compounds that enhance microglial phagocytosis and attenuate neuroinflammation without compromising neuronal viability. Pre‑clinical data indicate that JUJ‑016 crosses the blood–brain barrier (BBB) efficiently (brain/plasma ratio ≈ 0.85), exhibits oral bioavailability > 65 % in rodents, and demonstrates disease‑modifying activity in mouse models of Alzheimer’s disease (AD) and frontotemporal dementia (FTD). A first‑in‑human (FIH) Phase I study (NCT05872145) is currently recruiting healthy volunteers and is expected to report safety/tolerability data by Q3 2027. General discussions on social platforms like Facebook and